Michael P. Guarisco

Internal Medicine

4710 Oneal Ln Ste 112
Baton Rouge, LA 70817

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial.

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial.

Journal: Diabetes care

Published: April 09, 2013

Showing 1-1 of 1

Last Updated: 09/26/2026